News coverage about Align Technology (NASDAQ:ALGN) has trended somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Align Technology earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave news articles about the medical equipment provider an impact score of 46.0443948467131 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Shares of Align Technology (NASDAQ ALGN) opened at $258.43 on Friday. Align Technology has a twelve month low of $88.56 and a twelve month high of $266.41. The firm has a market capitalization of $20,720.40, a P/E ratio of 78.31, a price-to-earnings-growth ratio of 2.02 and a beta of 1.43.
Align Technology (NASDAQ:ALGN) last announced its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $1.01 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.82 by $0.19. The business had revenue of $385.30 million for the quarter, compared to analyst estimates of $359.80 million. Align Technology had a return on equity of 25.60% and a net margin of 19.98%. The company’s quarterly revenue was up 38.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.63 EPS. analysts predict that Align Technology will post 3.67 earnings per share for the current year.
A number of research firms recently issued reports on ALGN. Stifel Nicolaus reiterated a “buy” rating and issued a $225.00 target price (up from $205.00) on shares of Align Technology in a report on Thursday, October 19th. Morgan Stanley reiterated an “overweight” rating and issued a $220.00 target price (up from $195.00) on shares of Align Technology in a report on Friday, October 6th. Zacks Investment Research upgraded Align Technology from a “hold” rating to a “buy” rating and set a $227.00 price target on the stock in a research note on Monday, October 30th. Northcoast Research restated a “buy” rating and issued a $230.00 price target (up from $200.00) on shares of Align Technology in a research note on Tuesday, October 10th. Finally, Credit Suisse Group upgraded Align Technology to a “buy” rating and set a $276.00 price target on the stock in a research note on Thursday, January 4th. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $236.75.
In other Align Technology news, VP Emory Wright sold 5,025 shares of the business’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $263.68, for a total value of $1,324,992.00. Following the completion of the transaction, the vice president now directly owns 80,762 shares in the company, valued at approximately $21,295,324.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Joseph Lacob sold 29,724 shares of the company’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $260.91, for a total value of $7,755,288.84. The disclosure for this sale can be found here. In the last ninety days, insiders sold 52,849 shares of company stock worth $13,494,348. 1.60% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION WARNING: “Align Technology (NASDAQ:ALGN) Getting Somewhat Favorable Media Coverage, Study Finds” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/14/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-align-technology-algn-stock-price.html.
Align Technology Company Profile
Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.